Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pralatrexate

EU orphan designation number: EU/3/10/795   
Active ingredient: Pralatrexate
Indication: Treatment of Hodgkin's lymphoma
Sponsor: Allos Therapeutics Limited
71 Knowl Piece, Wilbury Way, Hitchin, Hertfordshire SG4 0TY, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2010 Centralised Orphan - Designation EMA/OD/061/10 (2010)6940 of 01/10/2010